Identification of Kinome Biomarkers and Therapeutic Rescue in cGMP-Linked Retinal Degeneration
Inherited retinal degenerations, such as Retinitis Pigmentosa (RP) and Leber's congenital amaurosis (LCA), are major causes of progressive and irreversible vision loss. The large number of genes associated with these disorders makes their clinical and molecular characterization difficult, while systemic biomarkers for disease progression or treatment response remain limited. These challenges were…
Inherited retinal degenerations, including Retinitis Pigmentosa and Leber's congenital amaurosis, are significant causes of irreversible vision loss. The sheer number of genes implicated in these disorders complicates both clinical and molecular characterization. There is a lack of systemic biomarkers to monitor disease progression or treatment response.
To tackle these challenges, researchers focused on cGMP-associated mechanisms that are common to Retinitis Pigmentosa and Leber's congenital amaurosis. This approach involved integrating systemic biomarker profiling with retinal outcomes.
Kinase activity analysis, or kinome analysis, was performed on peripheral blood mononuclear cells from healthy individuals and those with retinal disorders. This analysis differentiated the two states and captured therapy-associated signatures in a mouse model treated with LP-CN03, a liposomal formulation of a cGMP analog. The kinome analysis, being the first of its kind in a therapeutically responsive animal model, suggests that kinome analysis could be a valuable translational readout.
Further investigation into the therapeutic potential of LP-CN03 was conducted in a new CRISPR-Cas9-generated mouse model with a mutation in the AIPL1 gene, which is associated with Leber's congenital amaurosis. The results showed that treatment with LP-CN03 preserved the retinal structure and function, as evidenced by electroretinography, longitudinal optical coherence tomography, fundus imaging, optomotor testing, and increased expression of photoreceptor-specific genes.
These findings provide independent in vivo evidence that LP-CN03 has a neuroprotective effect in both cGMP-related Retinitis Pigmentosa and Leber's congenital amaurosis. Additionally, the study highlights the translational value of kinome profiling in the development of therapeutic strategies for these debilitating retinal disorders.
Rewritten by urgent.news; may contain errors — check the original.
Source: biorxiv.org